Tekla Life Sciences Investors Earnings

The next earnings date for Tekla Life Sciences Investors has not yet been scheduled.

Analyst Estimates of Tekla Life Sciences Investors Earnings

No Results.

Report Date	Estimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Tekla Life Sciences Investors Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
06/09/2025	After Market	---	---
12/07/2022	---	$-1.08	---
06/03/2022	---	$-3.03	---
12/03/2021	---	$1.32	---
09/30/2021	---	$0.67	---
06/04/2021	---	$1.30	---
03/31/2021	---	$0.65	---
12/04/2020	---	$3.83	---
09/30/2020	---	$1.94	---
06/05/2020	---	$1.29	---
03/31/2020	---	$0.64	---
12/05/2019	---	$-1.33	---
09/30/2019	---	$-0.68	---
06/05/2019	---	$-1.72	---
03/31/2019	---	$-0.86	---
12/04/2018	---	$2.12	---
09/30/2018	---	$1.08	---
06/01/2018	---	$-0.90	---
03/31/2018	---	$-0.45	---
12/05/2017	---	$1.90	---
09/30/2017	---	$0.97	---
06/02/2017	---	$1.27	---
03/31/2017	---	$0.63	---
12/01/2016	---	$2.69	---
09/30/2016	---	$1.38	---
06/03/2016	---	$-3.44	---
03/31/2016	---	$-1.72	---
12/31/2015	---	$-1.72	---
09/30/2015	---	$-1.28	---
06/30/2015	---	$-1.28	---
03/31/2015	---	$2.36	---
12/31/2014	---	$2.36	---
09/30/2014	---	$1.41	---
06/30/2014	---	$1.41	---
03/31/2014	---	$1.16	---
12/31/2013	---	$1.16	---
09/30/2013	---	$1.96	---
06/30/2013	---	$1.96	---
03/31/2013	---	$0.88	---
12/31/2012	---	$0.88	---
09/30/2012	---	$0.80	---
06/30/2012	---	$0.80	---
03/31/2012	---	$1.92	---
12/31/2011	---	$1.92	---
09/30/2011	---	$-0.19	---
06/30/2011	---	$-0.19	---
03/31/2011	---	$0.97	---
12/31/2010	---	$0.97	---

More About Tekla Life Sciences Investors

Website

https://www.teklacap.com/hql.html

Country

USA

Full Time Employees

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

“Tekla Life Sciences Investors Earnings” Can Refer to the Tekla Life Sciences Investors Earnings Date

Some people say “Tekla Life Sciences Investors earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Tekla Life Sciences Investors position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Tekla Life Sciences Investors Stock on the Earnings Date

If you own Tekla Life Sciences Investors stock (HQL) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Tekla Life Sciences Investors might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Tekla Life Sciences Investors shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Tekla Life Sciences Investors Earnings

You can contact us any time if you would like to ask questions about Tekla Life Sciences Investors earnings or anything else related to the stock market.